Special Issue "Adhesion and Integrins"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 October 2012)
Prof. Dr. Kairbaan Hodivala-Dilke
The Adhesion and Angiogenesis Laboratory, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London
Interests: Adhesion and Integrins, Tumour Angiogenesis, Cancer Cell Biology, Metastasis and Invasion and Breast Cancer
Cancer initiation, growth, progression and metastasis are all stages of the disease that involve changes in both cell-cell and cell-matrix adhesion. Such changes occur not only the tumour cell compartment but also in the stromal compartment, with changes in the adhesive capacity of immune cells, tumour associated fibroblasts, endothelial cells and so on. It is increasing evident that blockade of such adhesion molecules may have therapeutic value. The special issue of Cancers on ‘Adhesion and Integrins’ will include original research articles and review articles on the influence of adhesion molecules in cancer development and how we can exploit such changes for therapeutic advance.
Prof. Kairbaan Hodivala-Dilke
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- Immune infiltration
Review: RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis
Cancers 2012, 4(4), 1106-1145; doi:10.3390/cancers4041106
Received: 23 August 2012; in revised form: 9 October 2012 / Accepted: 22 October 2012 / Published: 26 October 2012| Download PDF Full-text (714 KB) | Download XML Full-text
Cancers 2013, 5(1), 27-47; doi:10.3390/cancers5010027
Received: 5 December 2012; in revised form: 9 January 2013 / Accepted: 11 January 2013 / Published: 15 January 2013| Download PDF Full-text (234 KB) | Download XML Full-text
Last update: 25 September 2012